Shire Biotech Denmark ApS: Financial statements 2017
CVR: 33358008
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Shire Biotech Denmark ApS (CVR 33358008) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 12,675,556 and a net result of DKK 860,343 compared with DKK 775,583 the year before. That is an increase of 39% compared with the year before. Equity in the 2017 report amounted to DKK 3,207,794. The solvency ratio was 32.4%. The company had 9 employees in the financial year.
- Gross Profit
- DKK 12,675,556
- Profit/Loss
- DKK 860,343
- Equity
- DKK 3,207,794
- Total Assets
- DKK 9,912,572
- Employees
- 9
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 12.7 mio. | 860 t. | 3.2 mio. | 9 |
| 2016 | - | 9.1 mio. | 776 t. | 2.3 mio. | - |
| 2015 | - | 9.7 mio. | 669 t. | 1.6 mio. | - |
| 2014 | - | 7.2 mio. | 343 t. | 903 t. | - |
| 2013 | - | 4.8 mio. | 232 t. | 561 t. | - |
Official annual report
Keep an eye on Shire Biotech Denmark ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
On August 1, 2017, the company changed its name from SHIRE DENMARK ApS to Shire Biotech Denmark ApS.
Shire Biotech Denmark ApS has published its annual report for 2016. Gross profit came to DKK 9,116,935, and the net result was DKK 775,583.
As of May 29, 2017, Kerstin Anna-Lena Engvall is registered as adm. dir. of Shire Biotech Denmark ApS.
As of May 29, 2017, Paul Michael Blanchfield has stepped down as director of Shire Biotech Denmark ApS.
As of April 21, 2017, Jacob Fredrik Westin has joined the board of directors of Shire Biotech Denmark ApS.
As of April 21, 2017, Johan Åke Östen Pettersson has joined the board of directors of Shire Biotech Denmark ApS.
As of April 21, 2017, Helen Alice Lillistone has left the board of directors of Shire Biotech Denmark ApS.
As of April 21, 2017, Paul Michael Blanchfield has left the board of directors of Shire Biotech Denmark ApS.
As of April 21, 2017, Amanda Miller has left the board of directors of Shire Biotech Denmark ApS.
As of April 21, 2017, Kerstin Anna-Lena Engvall is registered as chairman of Shire Biotech Denmark ApS.
About Shire Biotech Denmark ApS
Shire Biotech Denmark ApS was a Danish company of the type Anpartsselskab based in København V, founded in 2010. The company has been dissolved on 1 April 2018. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SHIRE DENMARK ApS and ApS STAKE NR. 1347. The company has 0 employees (2018). In 2017, the company reported a gross profit of DKK 12,675,556 and a net result of DKK 860,343 compared with DKK 775,583 the year before. Equity in the 2017 report amounted to DKK 3,207,794.